BioNTech (ADRs) Aktie
90,25
EUR
-1,90
EUR
-2,06
%
98,88
USD
-2,01
USD
-1,99
%
Werbung
BioNTech (ADRs) Aktie Analyse
| 14.03.25 | BioNTech (ADRs) Buy | Deutsche Bank AG | |
| 11.03.25 | BioNTech (ADRs) Buy | Goldman Sachs Group Inc. | |
| 11.03.25 | BioNTech (ADRs) Neutral | UBS AG | |
| 11.03.25 | BioNTech (ADRs) Buy | Deutsche Bank AG | |
| 10.03.25 | BioNTech (ADRs) Neutral | JP Morgan Chase & Co. | |
| 06.03.25 | BioNTech (ADRs) Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.01.25 | BioNTech (ADRs) Neutral | JP Morgan Chase & Co. | |
| 15.01.25 | BioNTech (ADRs) Buy | Goldman Sachs Group Inc. | |
|
Werbung
|
|||
| 17.12.24 | BioNTech (ADRs) Neutral | JP Morgan Chase & Co. | |
| 12.12.24 | BioNTech (ADRs) Buy | Jefferies & Company Inc. | |
| 11.12.24 | BioNTech (ADRs) Neutral | JP Morgan Chase & Co. | |
| 27.11.24 | BioNTech (ADRs) Buy | Deutsche Bank AG | |
| 26.11.24 | BioNTech (ADRs) Buy | Goldman Sachs Group Inc. | |
| 26.11.24 | BioNTech (ADRs) Buy | Jefferies & Company Inc. | |
| 19.11.24 | BioNTech (ADRs) Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 18.11.24 | BioNTech (ADRs) Buy | Goldman Sachs Group Inc. | |
| 15.11.24 | BioNTech (ADRs) Neutral | JP Morgan Chase & Co. | |
| 14.11.24 | BioNTech (ADRs) Buy | Goldman Sachs Group Inc. | |
| 12.11.24 | BioNTech (ADRs) Buy | Deutsche Bank AG | |
| 08.11.24 | BioNTech (ADRs) Buy | Goldman Sachs Group Inc. | |
| 05.11.24 | BioNTech (ADRs) Neutral | JP Morgan Chase & Co. | |
| 05.11.24 | BioNTech (ADRs) Buy | Deutsche Bank AG | |
| 04.11.24 | BioNTech (ADRs) Buy | Jefferies & Company Inc. | |
| 03.10.24 | BioNTech (ADRs) Buy | Deutsche Bank AG | |
| 02.10.24 | BioNTech (ADRs) Neutral | UBS AG | |
| 19.09.24 | BioNTech (ADRs) Buy | Deutsche Bank AG | |
| 18.09.24 | BioNTech (ADRs) Neutral | UBS AG | |
| 17.09.24 | BioNTech (ADRs) Buy | Jefferies & Company Inc. | |
| 16.09.24 | BioNTech (ADRs) Neutral | JP Morgan Chase & Co. | |
| 13.09.24 | BioNTech (ADRs) Hold | Jefferies & Company Inc. | |
| 09.09.24 | BioNTech (ADRs) Underweight | JP Morgan Chase & Co. | |
| 16.08.24 | BioNTech (ADRs) Hold | Jefferies & Company Inc. | |
| 16.08.24 | BioNTech (ADRs) Underweight | JP Morgan Chase & Co. | |
| 06.08.24 | BioNTech (ADRs) Neutral | Goldman Sachs Group Inc. | |
| 05.08.24 | BioNTech (ADRs) Hold | Jefferies & Company Inc. | |
| 24.05.24 | BioNTech (ADRs) Hold | Deutsche Bank AG | |
| 10.05.24 | BioNTech (ADRs) Neutral | UBS AG | |
| 08.05.24 | BioNTech (ADRs) Hold | Deutsche Bank AG | |
| 07.05.24 | BioNTech (ADRs) Neutral | Goldman Sachs Group Inc. | |
| 06.05.24 | BioNTech (ADRs) Hold | Jefferies & Company Inc. | |
| 23.04.24 | BioNTech (ADRs) Hold | Deutsche Bank AG | |
| 22.03.24 | BioNTech (ADRs) Hold | Deutsche Bank AG | |
| 21.03.24 | BioNTech (ADRs) Hold | Deutsche Bank AG | |
| 21.03.24 | BioNTech (ADRs) Neutral | Goldman Sachs Group Inc. | |
| 20.03.24 | BioNTech (ADRs) Hold | Jefferies & Company Inc. | |
| 20.03.24 | BioNTech (ADRs) Neutral | UBS AG | |
| 09.01.24 | BioNTech (ADRs) Neutral | UBS AG | |
| 14.12.23 | BioNTech (ADRs) Neutral | UBS AG | |
| 12.12.23 | BioNTech (ADRs) Hold | Jefferies & Company Inc. | |
| 28.11.23 | BioNTech (ADRs) Neutral | UBS AG | |
Werbung
Werbung